Avalo Therapeutics (AVTX) Preferred Shares (2017 - 2021)

Avalo Therapeutics has reported Preferred Shares for 5 years, with the latest figure at $1000.0 in Q1 2021.

• For the quarter ending Q1 2021, Preferred Shares fell 20.45% year-over-year to $1000.0; the trailing twelve-month figure through Mar 2021 stood at $1000.0 (down 20.45% YoY), and the FY2020 full-year result was $1000.0, down 65.0% from the prior year.
• Preferred Shares for Q1 2021 stood at $1000.0, roughly flat from $1000.0 in the prior quarter.
• The five-year high for Preferred Shares was $2857.0 in Q4 2018, with the low at $4.0 in Q1 2017.
• Historically, Preferred Shares has averaged $1672.0 across 5 years, with a median of $1257.0 in 2020.
• Annual changes were most pronounced in 2019 — Preferred Shares changed 0.0% — and 2020, when it tumbled 65.0%.
• Avalo Therapeutics' Preferred Shares stood at $4.0 in 2017, then jumped by 71325.0% to $2857.0 in 2018, then changed by 0.0% to $2857.0 in 2019, then tumbled by 65.0% to $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2021.
• The last three Preferred Shares figures came in at $1000.0 (Q1 2021), $1000.0 (Q4 2020), and $1257.0 (Q3 2020), per Business Quant data.